Sanara MedTech Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $103.1M | $86.7M | $65.0M | $45.8M | $24.1M |
| Gross profit | $95.6M | $78.5M | $57.1M | $39.5M | $21.8M |
| Operating income | $7.3M | $1.3M | -$4.2M | -$12.5M | -$7.4M |
| Operating expenses | $88.3M | $77.3M | $61.4M | $52.0M | $29.2M |
| Cost of revenue | $7.5M | $8.1M | $7.9M | $6.4M | $2.3M |
| Cash from operations | $6.8M | -$23,784 | -$3.2M | -$5.6M | -$4.8M |
| Capital expenditure | $4.6M | $205,848 | $265,246 | $147,015 | $171,867 |
| Free cash flow | $2.2M | -$229,632 | -$3.5M | -$5.7M | -$5.0M |
| Impairments | $28.3M | — | — | — | — |
| Total assets | $72.9M | $88.1M | $73.9M | $61.0M | $36.4M |
| Total liabilities | $67.0M | $49.2M | $29.3M | $19.3M | $6.2M |
| Total debt | $46.9M | $31.7M | $9.8M | — | — |
Shares outstanding 9.2M · Free float 30.7%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.